Barr E S & Co. Raises Position in Mettler-Toledo International Inc. (NYSE:MTD)

Barr E S & Co. increased its holdings in Mettler-Toledo International Inc. (NYSE:MTD) by 4.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 9,280 shares of the medical instruments supplier’s stock after purchasing an additional 433 shares during the period. Mettler-Toledo International accounts for 0.7% of Barr E S & Co.’s investment portfolio, making the stock its 27th biggest position. Barr E S & Co.’s holdings in Mettler-Toledo International were worth $11,356,000 as of its most recent SEC filing.

Several other institutional investors have also recently added to or reduced their stakes in the business. Alliancebernstein L.P. boosted its stake in Mettler-Toledo International by 9.9% in the 4th quarter. Alliancebernstein L.P. now owns 583,181 shares of the medical instruments supplier’s stock worth $713,627,000 after buying an additional 52,726 shares during the last quarter. Geode Capital Management LLC lifted its holdings in shares of Mettler-Toledo International by 2.0% during the 4th quarter. Geode Capital Management LLC now owns 558,471 shares of the medical instruments supplier’s stock worth $682,340,000 after acquiring an additional 11,032 shares during the period. Norges Bank acquired a new stake in shares of Mettler-Toledo International in the fourth quarter worth approximately $372,954,000. Principal Financial Group Inc. grew its holdings in Mettler-Toledo International by 13.9% in the fourth quarter. Principal Financial Group Inc. now owns 274,563 shares of the medical instruments supplier’s stock valued at $335,977,000 after purchasing an additional 33,456 shares during the period. Finally, Barclays PLC increased its position in Mettler-Toledo International by 8.3% during the third quarter. Barclays PLC now owns 256,602 shares of the medical instruments supplier’s stock worth $384,822,000 after purchasing an additional 19,609 shares during the last quarter. 95.07% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Mettler-Toledo International news, insider Christian Magloth sold 790 shares of the business’s stock in a transaction on Monday, February 24th. The shares were sold at an average price of $1,313.69, for a total transaction of $1,037,815.10. Following the sale, the insider now directly owns 734 shares of the company’s stock, valued at $964,248.46. The trade was a 51.84 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Gerry Keller sold 600 shares of the firm’s stock in a transaction on Monday, February 10th. The stock was sold at an average price of $1,351.34, for a total value of $810,804.00. Following the completion of the sale, the insider now directly owns 6 shares of the company’s stock, valued at approximately $8,108.04. This trade represents a 99.01 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.94% of the company’s stock.

Wall Street Analyst Weigh In

MTD has been the subject of several research reports. Wells Fargo & Company boosted their price objective on shares of Mettler-Toledo International from $1,350.00 to $1,400.00 and gave the company an “equal weight” rating in a research note on Monday, February 10th. Robert W. Baird boosted their target price on shares of Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the stock a “neutral” rating in a research report on Monday, February 10th. Citigroup raised Mettler-Toledo International from a “neutral” rating to a “buy” rating and set a $1,400.00 price target for the company in a report on Monday, April 7th. Finally, Evercore ISI lifted their price objective on Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the stock an “outperform” rating in a report on Monday, February 10th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $1,380.50.

Mettler-Toledo International Price Performance

Shares of MTD opened at $1,041.26 on Friday. Mettler-Toledo International Inc. has a 12-month low of $946.69 and a 12-month high of $1,546.93. The stock has a market capitalization of $21.70 billion, a P/E ratio of 25.69, a P/E/G ratio of 3.30 and a beta of 1.28. The firm’s 50 day moving average is $1,217.84 and its 200-day moving average is $1,275.83.

Mettler-Toledo International (NYSE:MTD) last issued its earnings results on Thursday, February 13th. The medical instruments supplier reported $12.41 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $11.76 by $0.65. Mettler-Toledo International had a negative return on equity of 591.54% and a net margin of 22.29%. As a group, equities research analysts forecast that Mettler-Toledo International Inc. will post 42.71 EPS for the current fiscal year.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.